The Texas Two-Step: Corporate Strategy or Legal Loophole?

Summary

In the latest episode of “Know More. Risk Better.,” host Winnie Cisar and Special Situations Legal Research Head Mark Lightner delve into the complexities of mass torts and bankruptcy, focusing on high-profile cases like Purdue Pharma’s. They unravel the impacts of third-party releases and the controversial Texas Two-Step strategy for companies facing mass tort liabilities. This episode is a must-listen for anyone interested in how landmark legal battles shape creditworthiness for companies with mass tort exposure.

Analysts

Winnie Cisar, CFA
Global Head of Strategy

Mark Lightner, Esq.
Head of Special Situations Legal Research

Credit in Transition: M&A, CLOs and AI with Octagon

Credit in Transition: M&A, CLOs and AI with Octagon

July 21, 2026
Geopolitics, the Dollar and the AI Bubble Debate

Geopolitics, the Dollar and the AI Bubble Debate

July 16, 2026
SpaceX at Scale: Valuation, Volatility and the Road Ahead

SpaceX at Scale: Valuation, Volatility and the Road Ahead

July 9, 2026

Know More. Risk Better.®

Sign up to receive our latest credit insights direct to your inbox.